FTC Says Study Documents Aren't Needed In Actavis Case
The Federal Trade Commission told a Georgia federal judge Friday it doesn't plan to use its studies about the pharmaceutical industry in a pay-for-delay trial against AbbVie Products LLC and other...To view the full article, register now.
Already a subscriber? Click here to view full article